Education and Training
Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney Function
The study will determine the efficacy of twice weekly hemodialysis in patients with residual kidney function.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- other: Twice weekly hemodialysis
- other: Thrice weekly hemodialysis
Eligibility
Inclusion Criteria:
- Stable dialysis patients able to provide consent
Exclusion Criteria:
- Use of antibiotics for last two months or expected antibiotic use
- Recent hospitalization or other event resulting in instability of food intake
- Residual kidney function < 2.5 mL/min
Ages Eligible for Study
18 Years - 85 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Recruiting